No synergy between fimasartan, rosuvastatin in hypertensive and dyslipidemic patients
20 May 2020
byJairia Dela Cruz
Concomitant use of fimasartan and rosuvastatin in patients with hypertension and dyslipidaemia does not appear to be synergistic in increasing concurrent control rate of the diseases, although either drug is effective against the target disease, according to a study.
No synergy between fimasartan, rosuvastatin in hypertensive and dyslipidemic patients
20 May 2020
